Literature DB >> 24158977

Fatty fish intake is associated with decreased occurrence of multiple sclerosis.

Maria Bäärnhielm1, Tomas Olsson, Lars Alfredsson.   

Abstract

BACKGROUND: High vitamin D levels have been associated with a decreased risk of developing multiple sclerosis (MS). The most important source of dietary vitamin D is fatty fish.
OBJECTIVE: The objective of this paper is to investigate the association between fish consumption and the risk of MS, including the interaction between fish intake and ultraviolet radiation (UVR) exposure habits.
METHODS: This study is based on the project Epidemiological Investigation of MS (EIMS), which is a Swedish population-based case-control study. The analysis included 1879 incident cases of MS and 4135 controls. Subjects who reported high fatty fish intake were compared regarding occurrence of MS with those who reported low intake by calculating odds ratio (OR) with 95% confidence interval (CI).
RESULTS: Frequent fatty fish intake was associated with decreased occurrence of MS (adjusted OR 0.82 (95% CI 0.68-0.98). There was no significant association between intake of lean fish and MS.
CONCLUSION: Fatty fish intake might decrease the risk for MS. A hypothetical explanation is that intake of fatty fish may compensate for vitamin D deficiency that is associated with increased MS risk.

Entities:  

Keywords:  Multiple sclerosis; case-control study; epidemiology; fatty fish; ultraviolet radiation (UVR) exposure; vitamin D

Mesh:

Substances:

Year:  2013        PMID: 24158977     DOI: 10.1177/1352458513509508

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  29 in total

Review 1.  Lifestyle and Environmental Factors in Multiple Sclerosis.

Authors:  Lars Alfredsson; Tomas Olsson
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

2.  Polyunsaturated fatty acids and the risk of multiple sclerosis.

Authors:  Kjetil Bjørnevik; Tanuja Chitnis; Alberto Ascherio; Kassandra L Munger
Journal:  Mult Scler       Date:  2017-02-03       Impact factor: 6.312

Review 3.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.

Authors:  Tomas Olsson; Lisa F Barcellos; Lars Alfredsson
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

Review 4.  Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.

Authors:  Insha Zahoor; Shailendra Giri
Journal:  Clin Rev Allergy Immunol       Date:  2021-04       Impact factor: 8.667

Review 5.  Immunoregulatory effects and therapeutic potential of vitamin D in multiple sclerosis.

Authors:  Wei Zhen Yeh; Melissa Gresle; Vilija Jokubaitis; Jim Stankovich; Anneke van der Walt; Helmut Butzkueven
Journal:  Br J Pharmacol       Date:  2020-08-05       Impact factor: 8.739

6.  MS risk in immigrants in the McDonald era: A population-based study in Ontario, Canada.

Authors:  Dalia L Rotstein; Ruth Ann Marrie; Colleen Maxwell; Sima Gandhi; Susan E Schultz; Kinwah Fung; Karen Tu
Journal:  Neurology       Date:  2019-11-05       Impact factor: 9.910

Review 7.  The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review.

Authors:  Leah J Mische; Ellen M Mowry
Journal:  Curr Treat Options Neurol       Date:  2018-03-17       Impact factor: 3.598

8.  Seafood, fatty acid biosynthesis genes, and multiple sclerosis susceptibility.

Authors:  Annette Langer-Gould; Lucinda J Black; Emmanuelle Waubant; Jessica B Smith; Jun Wu; Edlin G Gonzales; Xiaorong Shao; Corinna Koebnick; Robyn M Lucas; Anny Xiang; Lisa F Barcellos
Journal:  Mult Scler       Date:  2019-09-06       Impact factor: 6.312

Review 9.  The Swedish MS registry – clinical support tool and scientific resource.

Authors:  J Hillert; L Stawiarz
Journal:  Acta Neurol Scand       Date:  2015       Impact factor: 3.209

Review 10.  Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.

Authors:  N Grytten; Ø Torkildsen; K-M Myhr
Journal:  Acta Neurol Scand       Date:  2015       Impact factor: 3.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.